Recalls / Active ingredient / Cefdinir

Cefdinir

10 FDA drug recalls involving the active ingredient “Cefdinir”.

Date	Class	Product	Firm
2024-05-08	Class II	Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Ph	Lupin Pharmaceuticals Inc.
2024-04-24	Class II	Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured f	Lupin Pharmaceuticals Inc.
2024-04-24	Class II	Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured f	Lupin Pharmaceuticals Inc.
2020-07-02	Class II	Cefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: Lupin Phar	Lupin Pharmaceuticals Inc.
2019-11-01	Class III	Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals,	Lupin Pharmaceuticals Inc.
2019-11-01	Class III	Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle	Lupin Pharmaceuticals Inc.
2019-05-23	Class II	Cefdinir for Oral Suspension USP, 250mg/5mL, Powder for oral suspension, 60 mL bottle, Rx only, Manufactured f	Lupin Pharmaceuticals Inc.
2019-01-02	Class II	Cefdinir for Oral Suspension USP, 125mg/5mL, packaged in a) 60mL (NDC 68180-722-20), b)100mL (NDC 68180-722-10	Lupin Pharmaceuticals Inc.
2019-01-02	Class II	Cefdinir for Oral Suspension USP, 250mg/5mL, packaged in a) 60mL (NDC 68180-723-20), b)100mL (NDC 68180-723-10	Lupin Pharmaceuticals Inc.
2018-03-27	Class II	Lupin Cefdinir powder for Oral Suspension USP, 250 mg/5 mL in (a) 60 mL packs ( NDC 68180-723-20) and (b) 100	Lupin Pharmaceuticals Inc.